腾讯控股回购明细 证券时报·数据宝统计，腾讯控股在港交所公告显示，11月28日以每股609.000港元至616.500港元的价格 回购103.90万股，回购金额达6.36亿港元。该股当日收盘价611.500港元，平盘报收，全天成交额80.87亿 港元。 自11月18日以来公司已连续9日进行回购，合计回购923.20万股，累计回购金额57.21亿港元。 其间该股 累计下跌3.93%。 今年以来该股累计进行109次回购，合计回购1.31亿股，累计回购金额666.86亿港元。（数据宝） （文章来源：证券时报网） | 日期 | 回购股数（万股） | 回购最高价（港元） | 回购最低价（港元） | 回购金额（万港元） | | --- | --- | --- | --- | --- | | 2025.11.28 | 103.90 | 616.500 | 609.000 | 63560.93 | | 2025.11.27 | 103.60 | 620.000 | 609.000 | 63568.33 | | 2025.11.26 | 102.20 | 629.000 | 618.500 | 63565.95 | | 202 ...

智通财经APP讯，腾讯控股(00700)发布公告，于2025年11月28日，该公司斥资6.36亿港元回购103.9万股 股份，每股回购价609-616.5港元。 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 騰訊控股有限公司 呈交日期： 2025年11月28日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 00700 | 說明 | | | | | | | | 多櫃檯證券代號 | 80700 | RMB 說明 | | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | | 已發行股份（不包括庫存股份） ...

Core Viewpoint - Tencent's Q3 performance exceeded market expectations, with significant growth in revenue, gross profit, and adjusted net profit, driven by strong performance in its gaming, marketing, and fintech segments [1][2][3]. Group 1: Q3 Financial Performance - Tencent reported Q3 revenue of 192.87 billion yuan, a year-over-year increase of 15% and a quarter-over-quarter increase of 5%, surpassing the consensus estimate of 188.8 billion yuan [1]. - Gross profit reached 108.8 billion yuan, up 22% year-over-year and 4% quarter-over-quarter, also exceeding the expected 106.39 billion yuan [1]. - Adjusted net profit was 70.55 billion yuan, reflecting an 18% year-over-year increase and a 12% quarter-over-quarter increase, beating the consensus estimate of 65.97 billion yuan by 6.9% [1]. Group 2: Value-Added Services (VAS) - Domestic gaming revenue was 42.8 billion yuan, a 15% year-over-year increase, driven by stable contributions from games like "Delta Action" and "Honor of Kings" [2]. - International gaming revenue reached 20.8 billion yuan, a 43% year-over-year increase, exceeding expectations due to growth from Supercell games and strong sales of new titles [2]. Group 3: Marketing Business - Marketing revenue for Q3 was 36.2 billion yuan, a 21% year-over-year increase, surpassing the expected 35.6 billion yuan, driven by AI-enhanced advertising platforms [2]. - The introduction of Tencent's advertising AIM+ improved targeting and bidding capabilities, leading to increased ad exposure and advertiser investment [2]. Group 4: Fintech Performance - Fintech revenue was 58.2 billion yuan, a 10% year-over-year increase, supported by growth in commercial payment activities and consumer loan services [3]. - AI service demand contributed to revenue growth, with significant improvements in the capabilities of Tencent's AI models [3]. Group 5: Future Outlook - The company projects non-IFRS net profits of 257.02 billion yuan, 290.51 billion yuan, and 319.01 billion yuan for 2025, 2026, and 2027 respectively, indicating stable growth in gaming and advertising sectors [3].

Summary of Key Points Core Viewpoint - Tencent Holdings has been actively repurchasing its shares, with a total of 1.30 billion shares repurchased this year, amounting to HKD 66.05 billion, indicating a strong commitment to shareholder value amidst recent stock price declines [1][2][3]. Group 1: Share Buyback Details - On November 27, Tencent repurchased 1.036 million shares at a price range of HKD 609.000 to HKD 620.000, totaling HKD 63.568 million [1]. - Since November 18, the company has conducted buybacks for eight consecutive days, acquiring a total of 8.193 million shares for HKD 508.6 million, while the stock price has decreased by 3.93% during this period [1]. - Year-to-date, Tencent has executed 108 buybacks, totaling 130 million shares and an expenditure of HKD 66.05 billion [1]. Group 2: Stock Performance - The stock closed at HKD 611.500 on November 27, reflecting a decline of 1.29% for the day [1]. - The total trading volume for the day was HKD 9.503 billion, indicating significant market activity despite the stock price drop [1]. Group 3: Historical Buyback Data - The buyback prices have varied, with the highest recorded price being HKD 683.000 on October 2, and the lowest at HKD 386.400 on January 16 [2][3][4]. - The buyback strategy appears to be consistent, with multiple transactions occurring daily, demonstrating a proactive approach to managing share price and market perception [2][3][4].

每经AI快讯，11月27日，港交所文件显示，腾讯控股11月27日回购103.6万股股份，耗资约6.357亿港 元。 ...

格隆汇11月27日丨腾讯控股(00700.HK)发布公告，2025年11月27日耗资6.36亿港元回购103.6万股，回购 价格每股609-620港元。 ...

腾讯控股(00700)发布公告，于2025年11月27日，该公司斥资6.36亿港元回购103.6万股。 ...

如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 00700 | 說明 | | | | | | | 多櫃檯證券代號 | 80700 | RMB 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事件 | | 已發行股份（不包括庫存股份）數 目 | 佔有關事件前的現有已發 行股份（不包括庫存股 份）數目百分比 (註3) | 庫存股份數目 | 每股發行/出售價 (註4) | 已發行股份總 ...

Core Insights - Fangzhou Inc. and Tencent Healthcare have launched an "AI+Chronic Disease Management" solution, enhancing the integration of AI in China's healthcare sector [1][4][7] - The solution leverages Fangzhou's AI+H2H ecosystem and Tencent Cloud's technological capabilities, aiming to improve chronic disease management efficiency [2][6] - The partnership aligns with national health guidelines and supports the "Healthy China 2030" initiative, promoting digital transformation in healthcare [7] Company Overview - Fangzhou Inc. is a leading online chronic disease management platform in China, with 52.8 million registered users and 229,000 physicians as of June 30, 2025 [9] - The company specializes in AI-enabled precision medicine solutions and tailored medical care [9] Technological Framework - The solution is built on a robust technological foundation, utilizing Tencent Healthcare's TI platform for model training, evaluation, and deployment [6] - Tencent's vector database enhances the accuracy of medical knowledge retrieval, supporting the AI's factual outputs [6] Safety and Compliance - Fangzhou has implemented multiple safety measures to mitigate AI hallucinations in clinical settings, including reinforcement learning and rule-based supervision [5][6] - Compliance with regulatory standards for clinical AI is ensured through Tencent Healthcare's AI security measures [6]